The Association of Expressions of PTEN Gene and Nm23 Gene with Biological Behaviors in Breast Cancer
LU Jun,CHEN Yun-li,QIU Qian-cheng,MA Tao,QIN Zi-ke
DOI: https://doi.org/10.3760/cma.j.issn.1007-1245.2011.13.003
2011-01-01
Abstract:Objective To explore the expressions of PTEN gene, nm23 gene, progesterone receptor, and estrogen receptor in breast cancer and their clinical, values. Methods The expression levels of PTEN, nm23, progesterone receptor, and estrogen receptor were detected by immunohistochemistry(S-P method)in 42 samples of paraffin-embedded human breast cancer tissues and 12 samples of hyperplasia of mammary gland tissues. Results The high expression rate of PTEN gene was lower in breast cancer than in hyperplasia of mammary glands(P＜ 0.05). The expression of PTEN gene was not related with tumor size, histological grade, clinical stage and postoperative recurrence; but the high expression rate was higher in elder patients(＞ 45 years)than in young patients(＜ 45 years). The high expression of PTEN was significantly inversely correlated with axillary lymph node metastasis(P＜ 0.01), and had positive relationship with estrogen receptor(P＜ 0.05). The high expression of PTEN was negatively related with distant metastasis(P＜ 0.05), and had positive relationship with 5-year survival rate(P＜ 0.01). The high expression rate of nm23 gene did not differ significantly between breast cancer and hyperplasia of mammary glands(P＞ 0.05). The expression of nm23 gene was not related with tumor size, histological grade, clinical stage, postoperative recurrence, and age. The high expression of nm23 was significantly positively correlated with axillary lymph node metastasis(P＜ 0.01), but was negatively correlated with distant metastasis(P＜ 0.05), and had positive relationship with 5-year survival rate(P ＜ 0.01). Conclusions Abnormal expressions of PTEN gene and nm23 gene are closely associated with the tumorigenesis and development of primary breast cancer. Combined detection of expressions of PTEN, nm23, progesterone receptor and estrogen receptor can be used as a predictor for biological behaviors and prognosis of breast cancer.